glp-1 news today 2025 november ISPOR 2025: Exploring reasons for GLP-1 discontinuation The GLP-1 Access Gap: Mapping
Description
taking these drugs could grow from around 2 million today to 15 million in 2030, Goldman Sachs analyst Chris Shibutani writes in a report, increasing the size of the GLP-1 market from $10 billion to $100 billion in 2030
Side effect comparison: tirzepatide versus retatrutide Understanding the side effect differences helps you prepare for what the transition may bring
Thank you
How do prices of drugs for weight loss in the U.S
In mouse models, administration of purified P9 protein improved glucose homeostasis and reduced metabolic disease markers
